Clinical Trial Update: Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of Taxotere (docetaxel), Temodar (temozolomide), and cisplatin in patients with metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Taxotere (docetaxel)
• Temodar (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Melanoma | Phase 1 | Status: COMPLETED